News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
750,580 Results
Type
Article (49890)
Company Profile (317)
Press Release (700361)
Multimedia
Podcasts (100)
Webinars (20)
Section
Business (211837)
Career Advice (2120)
Deals (36505)
Drug Delivery (118)
Drug Development (83287)
Employer Resources (176)
FDA (17001)
Job Trends (15729)
News (358581)
Policy (35126)
Tag
Academia (2835)
Academic (2)
Accelerated approval (15)
Adcomms (27)
Allergies (118)
Alliances (51748)
ALS (134)
Alzheimer's disease (1611)
Antibody-drug conjugate (ADC) (206)
Approvals (17074)
Artificial intelligence (413)
Autoimmune disease (63)
Automation (25)
Bankruptcy (369)
Best Places to Work (12258)
BIOSECURE Act (21)
Biosimilars (153)
Biotechnology (202)
Bladder cancer (118)
Brain cancer (46)
Breast cancer (462)
Cancer (3665)
Cardiovascular disease (307)
Career advice (1789)
Career pathing (34)
CAR-T (224)
CDC (54)
Cell therapy (604)
Cervical cancer (31)
Clinical research (69352)
Collaboration (1313)
Company closure (4)
Compensation (908)
Complete response letters (45)
COVID-19 (2861)
CRISPR (78)
C-suite (560)
Cystic fibrosis (128)
Data (4256)
Decentralized trials (2)
Denatured (32)
Depression (98)
Diabetes (429)
Diagnostics (6882)
Digital health (34)
Diversity (11)
Diversity, equity & inclusion (45)
Drug discovery (181)
Drug pricing (175)
Drug shortages (29)
Duchenne muscular dystrophy (195)
Earnings (90328)
Editorial (51)
Employer branding (22)
Employer resources (153)
Events (123612)
Executive appointments (963)
FDA (19398)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1213)
Gene editing (167)
Generative AI (35)
Gene therapy (492)
GLP-1 (912)
Government (5175)
Grass and pollen (6)
Guidances (337)
Healthcare (20348)
HIV (45)
Huntington's disease (34)
IgA nephropathy (51)
Immunology and inflammation (209)
Immuno-oncology (15)
Indications (52)
Infectious disease (3089)
Inflammatory bowel disease (173)
Inflation Reduction Act (15)
Influenza (93)
Intellectual property (180)
Interviews (334)
IPO (16945)
IRA (52)
Job creations (3860)
Job search strategy (1508)
Kidney cancer (13)
Labor market (70)
Layoffs (559)
Leadership (24)
Legal (8496)
Liver cancer (88)
Longevity (12)
Lung cancer (521)
Lymphoma (256)
Machine learning (28)
Management (61)
Manufacturing (580)
MASH (134)
Medical device (14252)
Medtech (14275)
Mergers & acquisitions (20429)
Metabolic disorders (1059)
Multiple sclerosis (133)
NASH (17)
Neurodegenerative disease (205)
Neuropsychiatric disorders (51)
Neuroscience (2572)
NextGen: Class of 2025 (7119)
Non-profit (4927)
Now hiring (56)
Obesity (504)
Opinion (264)
Ovarian cancer (126)
Pain (153)
Pancreatic cancer (164)
Parkinson's disease (230)
Partnered (27)
Patents (397)
Patient recruitment (301)
Peanut (53)
People (60758)
Pharmaceutical (73)
Pharmacy benefit managers (26)
Phase I (21661)
Phase II (30390)
Phase III (22649)
Pipeline (2640)
Policy (268)
Postmarket research (2762)
Preclinical (9223)
Press Release (71)
Prostate cancer (187)
Psychedelics (47)
Radiopharmaceuticals (268)
Rare diseases (611)
Real estate (6222)
Recruiting (69)
Regulatory (24842)
Reports (51)
Research institute (2558)
Resumes & cover letters (363)
Rett syndrome (15)
RNA editing (11)
RSV (66)
Schizophrenia (124)
Series A (201)
Series B (153)
Service/supplier (13)
Sickle cell disease (78)
Special edition (23)
Spinal muscular atrophy (155)
Sponsored (36)
Startups (3824)
State (2)
Stomach cancer (16)
Supply chain (97)
Tariffs (84)
The Weekly (66)
Vaccines (982)
Venture capital (63)
Weight loss (334)
Women's health (57)
Worklife (18)
Date
Today (6)
Last 7 days (523)
Last 30 days (2215)
Last 365 days (31486)
2025 (24688)
2024 (36410)
2023 (41347)
2022 (52603)
2021 (57322)
2020 (56299)
2019 (49437)
2018 (37431)
2017 (33560)
2016 (33633)
2015 (39690)
2014 (33357)
2013 (28362)
2012 (30555)
2011 (31217)
2010 (29446)
Location
Africa (847)
Alabama (76)
Alaska (7)
Arizona (283)
Arkansas (14)
Asia (41325)
Australia (6867)
California (9171)
Canada (2811)
China (839)
Colorado (389)
Connecticut (408)
Delaware (249)
Europe (90368)
Florida (1366)
Georgia (311)
Hawaii (3)
Idaho (66)
Illinois (746)
India (46)
Indiana (442)
Iowa (18)
Japan (309)
Kansas (120)
Kentucky (36)
Louisiana (18)
Maine (77)
Maryland (1238)
Massachusetts (6798)
Michigan (302)
Minnesota (546)
Mississippi (4)
Missouri (112)
Montana (31)
Nebraska (25)
Nevada (106)
New Hampshire (75)
New Jersey (2548)
New Mexico (28)
New York (2513)
North Carolina (1319)
North Dakota (9)
Northern California (4181)
Ohio (287)
Oklahoma (21)
Oregon (38)
Pennsylvania (1924)
Puerto Rico (18)
Rhode Island (43)
South America (1216)
South Carolina (49)
South Dakota (1)
Southern California (3553)
Tennessee (146)
Texas (1421)
United States (33698)
Utah (276)
Virginia (228)
Washington D.C. (79)
Washington State (777)
West Virginia (4)
Wisconsin (90)
Wyoming (1)
750,580 Results for "opko health inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
OPKO Health to Participate in Two Upcoming Investor Conferences
May 15, 2025
·
1 min read
Press Releases
OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development
June 10, 2025
·
7 min read
Press Releases
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress
July 9, 2025
·
6 min read
Press Releases
OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results
May 1, 2025
·
11 min read
Press Releases
OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025
April 17, 2025
·
1 min read
GLP-1
OPKO and Entera Link Up to Advance First Oral GLP-1/Glucagon Drug Into Clinic
Under the terms of the agreement, OPKO will accept 60% of the development costs, while Entera will shoulder 40%.
March 18, 2025
·
2 min read
·
Tristan Manalac
BioMidwest
OPKO Health to Participate in the 2024 Jefferies Global Healthcare Conference
OPKO Health, Inc. announced that management will be participating in the Jefferies Global Healthcare Conference, being held June 4-6, 2024 at the Marriott Marquis in New York City.
May 31, 2024
·
1 min read
Press Releases
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
June 25, 2025
·
5 min read
Business
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
OPKO Health, Inc. reports business highlights and financial results for the three months ended March 31, 2024.
May 7, 2024
·
11 min read
Press Releases
OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results
February 28, 2025
·
12 min read
1 of 75,058
Next
